Article Search

Colonoscopy Intervals and Colorectal Cancer Incidence after Adenoma Removal

This one could reshape post-polypectomy surveillance. In nearly 11,000 patients with high-risk adenomas, waiting 5 years instead of 3 for the first surveillance colonoscopy was noninferior for colorectal cancer incidence (under 1% in both arms), with no apparent shift toward later-stage disease and roughly half as many colonoscopies. The 3-year arm picked up more advanced adenomas (15% vs 11%), but that didn't translate into fewer or earlier cancers. Caveats: this is an interim analysis that only narrowly met noninferiority, and only about two-thirds of patients completed 5-year surveillance, so the 10-year data will be the real test before guidelines move.

Read More »

Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis

This is a large, well-designed negative trial. In more than 142,000 adults aged 50 to 77 in England, adding three annual rounds of the Galleri multicancer blood test to usual care did not reduce stage III/IV diagnoses across 12 prespecified cancers. There's an intriguing but non-significant trend toward fewer stage IV cancers, so longer follow-up is the real story to watch, and safety wasn't an issue (fewer than 1% had trial-related adverse events, none serious). For now this doesn't support routine MCED screening outside a trial, so have that conversation ready when patients ask about ordering it.

Read More »

Keyword Search

  • Cancer Types

  • Month Contributed

  • Show FCS Articles Only

  • Sort Order

  • Number of Posts